CHICAGO, June 3, 2014 (GLOBE NEWSWIRE) -- ASCO Annual Meeting: Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, announced today that three abstracts on its lead candidate, CRLX101, were included in the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago from May 30 through June 3.
Help employers find you! Check out all the jobs and post your resume.
